APA
FLNA

American Portfolios Advisors’s Filana Therapeutics FLNA Stock Holding History

American Portfolios Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$96.2K Buy
+2,300
New +$62.1K ﹤0.01% 1382
2021
Q4 		– Sell
-8,200
Closed -$509K – 3583
2021
Q3 		$509K Buy
+8,200
New +$684K 0.02% 700

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Portfolios Advisors's FLNA Position: Q3 2022 in Review

American Portfolios Advisors opened a new position in Filana Therapeutics (FLNA) in Q3 2022: 2,300 shares worth $96.2K. The stake represents ﹤0.01% of the portfolio and ranks #1382 among its holdings. This is a return to the name: American Portfolios Advisors previously reported a position in FLNA as recently as Q3 2021.

American Portfolios Advisors first reported a position in FLNA in Q3 2021 and has held it in 2 quarters since. The position peaked at $509K in Q3 2021. 175 funds tracked by Wall St. Rank hold FLNA as of Q3 2022.

  • American Portfolios Advisors held 2,300 shares of Filana Therapeutics worth $96.2K as of Q3 2022.
  • Filana Therapeutics was a new American Portfolios Advisors position in Q3 2022.
  • Filana Therapeutics made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1382 holding.
  • American Portfolios Advisors first reported a position in Filana Therapeutics in Q3 2021 and has held it in 2 quarters since.
  • American Portfolios Advisors's Filana Therapeutics position peaked at $509K in Q3 2021.
  • 175 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.